Updated on 7 September 2012
BioTek's Synergy NEO was selected from among seven products. Photo: Bigstock
Singapore: BioTek Instruments has received the 2012 Drug Discovery Product of the Year - Scientists' Choice Award for their Synergy NEO HTS Multi-Mode Microplate Reader. The award, sponsored by SelectScience, was announced September 5 at ELRIG Drug Discovery in Manchester, UK.
BioTek Instruments, headquartered in the USA, designs, manufactures and markets microplate instrumentation and software.
"This award is such a special recognition from our customers; we're delighted to have our Synergy NEO foremost recognized among many cutting-edge drug discovery technologies," said Mr Gary Barush, BioTek's director of marketing & sales. "In return, we promise to continue innovating microplate-based solutions to benefit drug discovery applications."
BioTek's Synergy NEO was selected among seven product finalists, as nominated by SelectScience members. NEO is specifically designed for streamlined screening applications and core laboratories. Patented hybrid technology combines filter- and monochromator-based optics in the compact Synergy NEO for increased flexibility, speed and performance. Full spectrum reading in both fluorescent and absorbance modes, plus multiple parallel detectors decrease measuring time, and dedicated filter-based optics are suited for live cell assays. Additionally, an optional plate stacker with a six-second plate exchange time increases efficiency and walk-away automation. Powerful and user-friendly Gen5 data analysis software allows custom protocol creation, data processing and export flexibility.